Laboratory Capital Expenditures vs Begin Period Cash Flow Analysis

LH Stock

USD 198.40 0.05 0.03%

Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Capital Expenditures and its Begin Period Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Capital Expenditures vs Begin Period Cash Flow

Capital Expenditures vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Capital Expenditures account and Begin Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Laboratory's Capital Expenditures and Begin Period Cash Flow is 0.54. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Capital Expenditures and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Laboratory of are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Capital Expenditures i.e., Laboratory's Capital Expenditures and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Capital Expenditures

Capital Expenditures are funds used by Laboratory to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Laboratory operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

As of now, Laboratory's Tax Provision is increasing as compared to previous years. The Laboratory's current Enterprise Value is estimated to increase to about 8.7 B, while Selling General Administrative is projected to decrease to under 1.1 B.

	2021	2022	2023	2024 (projected)
Gross Profit	5.6B	4.4B	3.1B	1.9B
Total Revenue	16.1B	14.9B	12.2B	12.8B

Gross Profit Total Revenue

Laboratory fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Inventory	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity
Common Stock Shares Outstanding		0.58	0.51	0.52	0.47	0.41	0.66	0.48	0.49	0.31	0.62	0.09	0.31	0.44	0.7	0.32	0.11	0.66	0.41	0.66	0.64	0.26	0.32	0.19	0.94	0.9
Total Assets	0.58		0.62	0.69	0.98	0.95	0.93	0.95	0.92	0.54	0.99	0.43	0.54	0.96	0.82	0.85	0.39	0.98	0.94	0.96	0.9	-0.01	0.85	0.76	0.57	0.32
Other Current Liab	0.51	0.62		0.81	0.65	0.55	0.45	0.68	0.47	0.53	0.6	0.53	0.53	0.68	0.53	0.4	-0.02	0.57	0.64	0.51	0.6	0.41	0.5	0.41	0.46	0.18
Total Current Liabilities	0.52	0.69	0.81		0.72	0.74	0.59	0.74	0.73	0.26	0.68	0.54	0.26	0.7	0.37	0.71	0.03	0.63	0.67	0.6	0.53	0.69	0.75	0.7	0.53	0.35
Total Stockholder Equity	0.47	0.98	0.65	0.72		0.96	0.84	0.98	0.92	0.56	0.95	0.53	0.56	0.99	0.72	0.87	0.28	0.92	0.97	0.88	0.83	0.0	0.91	0.84	0.48	0.19
Property Plant And Equipment Net	0.41	0.95	0.55	0.74	0.96		0.85	0.94	0.94	0.47	0.93	0.54	0.47	0.94	0.63	0.93	0.3	0.9	0.94	0.88	0.75	0.1	0.94	0.9	0.46	0.2
Net Debt	0.66	0.93	0.45	0.59	0.84	0.85		0.78	0.88	0.3	0.96	0.22	0.3	0.78	0.86	0.78	0.55	0.97	0.75	0.99	0.92	0.0	0.68	0.6	0.61	0.48
Retained Earnings	0.48	0.95	0.68	0.74	0.98	0.94	0.78		0.89	0.57	0.92	0.61	0.57	0.98	0.67	0.84	0.1	0.87	0.96	0.83	0.77	0.04	0.91	0.84	0.54	0.2
Accounts Payable	0.49	0.92	0.47	0.73	0.92	0.94	0.88	0.89		0.27	0.92	0.44	0.27	0.87	0.63	0.96	0.3	0.88	0.85	0.87	0.76	0.13	0.91	0.87	0.54	0.34
Cash	0.31	0.54	0.53	0.26	0.56	0.47	0.3	0.57	0.27		0.47	0.36	1.0	0.63	0.52	0.24	0.04	0.5	0.7	0.45	0.45	-0.24	0.46	0.34	0.35	0.05
Non Current Assets Total	0.62	0.99	0.6	0.68	0.95	0.93	0.96	0.92	0.92	0.47		0.39	0.47	0.92	0.85	0.83	0.43	0.99	0.9	0.98	0.92	-0.01	0.81	0.72	0.59	0.37
Non Currrent Assets Other	0.09	0.43	0.53	0.54	0.53	0.54	0.22	0.61	0.44	0.36	0.39		0.36	0.55	0.23	0.44	-0.36	0.32	0.52	0.27	0.3	0.21	0.59	0.59	0.22	-0.17
Cash And Short Term Investments	0.31	0.54	0.53	0.26	0.56	0.47	0.3	0.57	0.27	1.0	0.47	0.36		0.63	0.52	0.25	0.04	0.5	0.71	0.45	0.45	-0.24	0.46	0.34	0.35	0.05
Net Receivables	0.44	0.96	0.68	0.7	0.99	0.94	0.78	0.98	0.87	0.63	0.92	0.55	0.63		0.7	0.83	0.22	0.89	0.98	0.84	0.8	-0.02	0.9	0.81	0.47	0.14
Non Current Liabilities Total	0.7	0.82	0.53	0.37	0.72	0.63	0.86	0.67	0.63	0.52	0.85	0.23	0.52	0.7		0.48	0.46	0.88	0.67	0.88	0.96	-0.23	0.44	0.32	0.64	0.43
Other Current Assets	0.32	0.85	0.4	0.71	0.87	0.93	0.78	0.84	0.96	0.24	0.83	0.44	0.25	0.83	0.48		0.29	0.79	0.83	0.78	0.63	0.18	0.93	0.94	0.4	0.22
Other Stockholder Equity	0.11	0.39	-0.02	0.03	0.28	0.3	0.55	0.1	0.3	0.04	0.43	-0.36	0.04	0.22	0.46	0.29		0.47	0.23	0.52	0.5	-0.22	0.12	0.1	-0.1	0.07
Total Liab	0.66	0.98	0.57	0.63	0.92	0.9	0.97	0.87	0.88	0.5	0.99	0.32	0.5	0.89	0.88	0.79	0.47		0.87	1.0	0.93	-0.03	0.76	0.66	0.63	0.43
Total Current Assets	0.41	0.94	0.64	0.67	0.97	0.94	0.75	0.96	0.85	0.7	0.9	0.52	0.71	0.98	0.67	0.83	0.23	0.87		0.83	0.75	-0.03	0.92	0.83	0.46	0.14
Short Long Term Debt Total	0.66	0.96	0.51	0.6	0.88	0.88	0.99	0.83	0.87	0.45	0.98	0.27	0.45	0.84	0.88	0.78	0.52	1.0	0.83		0.92	-0.04	0.73	0.63	0.63	0.46
Intangible Assets	0.64	0.9	0.6	0.53	0.83	0.75	0.92	0.77	0.76	0.45	0.92	0.3	0.45	0.8	0.96	0.63	0.5	0.93	0.75	0.92		-0.11	0.58	0.47	0.57	0.36
Short Term Debt	0.26	-0.01	0.41	0.69	0.0	0.1	0.0	0.04	0.13	-0.24	-0.01	0.21	-0.24	-0.02	-0.23	0.18	-0.22	-0.03	-0.03	-0.04	-0.11		0.18	0.19	0.26	0.32
Inventory	0.32	0.85	0.5	0.75	0.91	0.94	0.68	0.91	0.91	0.46	0.81	0.59	0.46	0.9	0.44	0.93	0.12	0.76	0.92	0.73	0.58	0.18		0.95	0.42	0.16
Property Plant And Equipment Gross	0.19	0.76	0.41	0.7	0.84	0.9	0.6	0.84	0.87	0.34	0.72	0.59	0.34	0.81	0.32	0.94	0.1	0.66	0.83	0.63	0.47	0.19	0.95		0.3	0.06
Common Stock	0.94	0.57	0.46	0.53	0.48	0.46	0.61	0.54	0.54	0.35	0.59	0.22	0.35	0.47	0.64	0.4	-0.1	0.63	0.46	0.63	0.57	0.26	0.42	0.3		0.87
Common Stock Total Equity	0.9	0.32	0.18	0.35	0.19	0.2	0.48	0.2	0.34	0.05	0.37	-0.17	0.05	0.14	0.43	0.22	0.07	0.43	0.14	0.46	0.36	0.32	0.16	0.06	0.87

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	98.6M	98M	97.5M	91.6M	87.6M	96.0M
Total Assets	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Other Current Liab	942.4M	1.4B	1.4B	1.1B	804M	502.9M
Total Current Liabilities	1.9B	2.6B	3.1B	2.8B	3.2B	3.4B
Total Stockholder Equity	7.6B	9.4B	10.3B	10.1B	7.9B	8.3B
Property Plant And Equipment Net	2.6B	2.7B	2.8B	3.0B	2.9B	3.1B
Net Debt	6.7B	5.4B	4.9B	5.9B	5.4B	5.7B
Retained Earnings	7.9B	9.4B	10.5B	10.6B	7.9B	8.3B
Accounts Payable	632.3M	638.9M	621.3M	934.8M	827.5M	868.9M
Cash	337.5M	1.3B	1.5B	430M	536.8M	290.8M
Non Current Assets Total	15.0B	14.9B	15.1B	15.5B	13.0B	13.6B
Non Currrent Assets Other	435.4M	410M	462.6M	432.7M	536.5M	270.8M
Cash And Short Term Investments	337.5M	1.3B	1.5B	430M	536.8M	299.7M
Net Receivables	2.0B	3.0B	3.0B	3.0B	2.1B	2.2B
Liabilities And Stockholders Equity	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Non Current Liabilities Total	7.8B	7.6B	7.3B	7.0B	5.6B	3.1B
Other Current Assets	373.7M	364.8M	478.1M	707M	655.3M	688.1M
Other Stockholder Equity	26.8M	110.3M	(192M)	(493.2M)	38.4M	36.5M
Total Liab	10.5B	10.7B	10.1B	10.1B	8.8B	9.3B
Total Current Assets	3.0B	5.1B	5.3B	4.6B	3.8B	4.0B
Short Long Term Debt Total	7.1B	6.8B	6.3B	6.3B	6.0B	6.3B
Intangible Assets	4.0B	4.0B	3.7B	3.9B	3.3B	2.0B
Short Term Debt	621.1M	575.4M	199M	492.8M	1.2B	1.2B
Inventory	244.7M	423.2M	401.4M	470.6M	474.6M	498.3M
Property Plant And Equipment Gross	2.6B	2.7B	5.2B	5.7B	5.8B	6.1B
Accumulated Other Comprehensive Income	(372.4M)	(161.9M)	(192M)	(493.2M)	(59.3M)	(62.3M)
Other Liab	1.3B	1.4B	1.2B	1.1B	1.2B	702.7M
Other Assets	356.5M	350.9M	484.2M	440.3M	506.3M	531.7M
Long Term Debt	5.8B	5.4B	5.4B	5.0B	4.1B	3.1B
Property Plant Equipment	2.7B	2.8B	2.8B	3.0B	3.4B	3.6B
Good Will	7.9B	7.8B	8.0B	8.1B	6.1B	4.4B
Current Deferred Revenue	451M	506.5M	558.5M	582.1M	421.7M	442.8M
Net Tangible Assets	(4.3B)	(2.4B)	(1.4B)	(2.0B)	(1.8B)	(1.9B)
Long Term Debt Total	5.9B	5.5B	5.5B	5.1B	5.9B	4.8B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.

	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.46)

Dividend Share

2.88

Earnings Share

4.33

Revenue Per Share

139.628

Quarterly Revenue Growth

0.035

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Capital Expenditures vs Begin Period Cash Flow Analysis

Capital Expenditures vs Begin Period Cash Flow

Capital Expenditures vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Capital Expenditures

Begin Period Cash Flow

Laboratory fundamental ratios Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Laboratory Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Assets Total	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Stockholder Equity
Short Long Term Debt Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.36	Non Currrent Assets Other
Short Term Debt	- 0.24	Cash And Short Term Investments
Short Term Debt	- 0.24	Cash
Short Term Debt	- 0.23	Non Current Liabilities Total
Short Term Debt	- 0.22	Other Stockholder Equity
Common Stock Total Equity	- 0.17	Non Currrent Assets Other